NAT 1 polymorphisms and cancer risk : a systematic review and meta-analysis

@inproceedings{Zhang2015NAT1P,
  title={NAT 1 polymorphisms and cancer risk : a systematic review and meta-analysis},
  author={Kunyi Zhang and Lijuan Gao and Yuqi Wu and Jianyi Chen and Chengguang Lin and Shaohua Liang and Jianxin Su and Jinming Ye and Xuyu He},
  year={2015}
}
Purpose: To investigate the association between the N-acetyltransferase 1 (NAT1) slow and rapid acetylation phenotypes with cancer risk based on a meta-analysis. Methods: Previously published case-control studies were retrieved from PubMed, Embase, and Web of Science. Odds ratios (ORs) with 95% confidence intervals (CIs) were determined to assess the relationship between NAT1 polymorphisms and cancer risk. Results: A total of 73 studies (24874 cases and 30226 controls) were included in this… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 89 REFERENCES

Real-time PCR analysis of the N-acetyltransferase NAT1 allele

S Fronhoffs, T Bruning, +8 authors Y. Ko
  • Carcinogenesis
  • 2001
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Heterocyclic amines and genotype of N-acetyltransferases Nat1 polymorphisms and cancer risk

PJ Rovito, PD Morse, +4 authors GP. Haas
  • Int J Clin Exp Med
  • 2015
VIEW 1 EXCERPT

Genome variation and personalized cancer medicine

TJ Hudson
  • J Intern Med
  • 2013
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…